EAB-318

N/A

Report date: 2022/05/05 14:16:51

Base Information

Drug NameEAB-318
Drug Alias NameEAB-318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Holdings LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Holdings LLC
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A